HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary stent implantation without coumadin in acute myocardial infarction.

AbstractOBJECTIVES:
We tested the feasibility and efficacy of primary stent implantation without Coumadin in 74 patients within 8 h of the onset of acute myocardial infarction.
BACKGROUND:
Although stent implantation in patients with effort angina provides better short- and long-term outcomes than balloon angioplasty, it is not clear whether primary stent implantation is applicable or effective in acute myocardial infarction.
METHODS:
Primary sent implantation was attempted when 1) the lesion was not located distally in the main coronary branches, 2) the coronary artery did not show any severe calcification or excessive bending proximal to the lesion on fluoroscopy, and 3) the arterial diameter was > or = 2.5 mm. The results (group S) were compared with those of primary balloon angioplasty (group P). Poststenting regimens contained ticlopidine and aspirin without Coumadin. Poststenting inflation was performed with > or = 12 atm.
RESULTS:
Stent implantation was successful in 72 patients. Stent thrombosis was noted in only one patient who was not given ticlopidine, aspirin or Coumadin. The rates of restenosis and frequency of major clinical events during the hospital period in groups S and P were 0% versus 13.2% (p = 0.007) and 2.8% versus 18.6% (p = 0.009), respectively. Kaplan-Meier analysis demonstrated that cumulative 90-day clinical event-free rates in groups P and S were 98.1 +/- 16.0% versus 79.4 +/- 43.7% (p = 0.0068), and that 180-day rates were 86.5 +/- 38.4% versus 64.2 +/- 49.7% (p = 0.014).
CONCLUSIONS:
Primary stent implantation can improve clinical outcomes of patients with acute myocardial infarction when the stent is dilated adequately and antiplatelet drugs are used.
AuthorsS Saito, F G Hosokawa, K Kim, S Tanaka, S Miyake
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 28 Issue 1 Pg. 74-81 (Jul 1996) ISSN: 0735-1097 [Print] United States
PMID8752797 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Ticlopidine
  • Aspirin
Topics
  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Aspirin (therapeutic use)
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Disease (diagnostic imaging, epidemiology, therapy)
  • Disease-Free Survival
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnostic imaging, epidemiology, therapy)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Recurrence
  • Stents
  • Ticlopidine (therapeutic use)
  • Time Factors
  • Treatment Outcome
  • Warfarin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: